TFF Pharmaceuticals, Inc. financial data

Symbol
TFFP on Nasdaq
Location
2600 Via Fortuna, Suite 360, Austin, TX
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 264 % -73.3%
Debt-to-equity 32.4 % +253%
Return On Equity -225 % -46.9%
Return On Assets -170 % -21.1%
Operating Margin -1.63K % +52.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.47M shares -90.4%
Common Stock, Shares, Outstanding 3.25M shares -91%
Entity Public Float 16.5M USD -88.1%
Common Stock, Value, Issued 3.25K USD -91%
Weighted Average Number of Shares Outstanding, Basic 3.67M shares +153%
Weighted Average Number of Shares Outstanding, Diluted 3.67M shares +153%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.2M USD +53.2%
Research and Development Expense 11.5M USD -22.4%
General and Administrative Expense 9.24M USD -27.2%
Operating Income (Loss) -19.5M USD +27%
Nonoperating Income (Expense) 157K USD +230%
Net Income (Loss) Attributable to Parent -19.4M USD +27.4%
Earnings Per Share, Basic -7.13 USD/shares +79.1%
Earnings Per Share, Diluted -7.13 USD/shares +79.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.39M USD -42.7%
Assets, Current 5.88M USD -37.5%
Property, Plant and Equipment, Net 1.76M USD -18.4%
Operating Lease, Right-of-Use Asset 78.9K USD -50.2%
Other Assets, Noncurrent 7.69K USD 0%
Assets 9.5M USD -30%
Accounts Payable, Current 1.36M USD +34.9%
Employee-related Liabilities, Current 4.43K USD
Accrued Liabilities, Current 2.16M USD
Contract with Customer, Liability, Current 25K USD
Liabilities, Current 3.62M USD +198%
Operating Lease, Liability, Noncurrent 10.9K USD -88.1%
Liabilities 3.62M USD +181%
Accumulated Other Comprehensive Income (Loss), Net of Tax -185K USD -11.6%
Retained Earnings (Accumulated Deficit) -129M USD -17.8%
Stockholders' Equity Attributable to Parent 5.88M USD -52.1%
Liabilities and Equity 9.5M USD -30%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.14M USD +28%
Net Cash Provided by (Used in) Financing Activities 901K USD
Net Cash Provided by (Used in) Investing Activities -137K USD +71.2%
Common Stock, Shares Authorized 180M shares +100%
Common Stock, Shares, Issued 3.25M shares -91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.27M USD +48.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.39M USD -42.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 15.3K USD
Deferred Tax Assets, Valuation Allowance 27.5M USD +23.2%
Deferred Tax Assets, Gross 27.5M USD +23.2%
Operating Lease, Liability 74.1K USD -52%
Payments to Acquire Property, Plant, and Equipment 137K USD -71.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.4M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid 76K USD -57.5%
Operating Lease, Liability, Current 74.1K USD -9.54%
Lessee, Operating Lease, Liability, to be Paid, Year Two 38K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 38K USD -58.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 91K USD
Deferred Tax Assets, Operating Loss Carryforwards 18M USD +17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38K USD
Operating Lease, Payments 22.3K USD +3.66%
Additional Paid in Capital 122M USD +14.2%
Depreciation, Depletion and Amortization 140K USD +13.8%
Share-based Payment Arrangement, Expense 608K USD -26.3%
Operating Leases, Future Minimum Payments Due 194K USD +824%
Interest Expense 15.6K USD